4 terminated. 4 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 4 | Terminated 4 |
Follow Aprepitant: new trials by email Literature Review of Aprepitant trials Research Report on Aprepitant
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Dual-dose Aprepitant to Reduce Postoperative Nausea and Vomiting After Laparoscopic Bariatric Surgery. Aprepitant 80 mg, Placebo - Postoperative Nausea and Vomiting, Bariatric Surgery | Phase 4 | Terminated | Insel Gruppe AG, University Hospital Bern | 71 | 2022-03-17 | 2025-02-27 |
| Effect of Neurokinin-1 Receptor (NK1R) Antagonism on Pruritus in Patients With Sezary Syndrome Aprepitant, Placebo - Sezary Syndrome, Pruritus | Phase 4 | Terminated | Vanderbilt University Medical Center | 7 | 2012-02-01 | 2017-05-10 |
| Pharmacokinetic Study on the Addition of Aprepitant to Cisplatin - Etoposide Treatment in Lung Cancer Patients aprepitant, Dexamethasone and Ondansetron during CE-treatment - Tumor | Phase 4 | Terminated | Radboud University Medical Center | 20 | 2008-03-01 | 2020-11-30 |
| Aprepitant for Prevention of Postoperative Nausea and Vomiting in Elective Hysterectomy Aprepitant, Placebo - Postoperative Nausea and Vomiting | Phase 4 | Terminated | Mayo Clinic | 256 | 2007-07-01 | 2012-03-30 |
Postoperative Nausea and Vomiting (2) · Nausea (1) · Neoplasms (1) · Pruritus (1) · Sezary Syndrome (1)
Insel Gruppe AG, University Hospital Bern (1) · Mayo Clinic (1) · Radboud University Medical Center (1) · Vanderbilt University Medical Center (1)
United States (2) · Netherlands (1) · Switzerland (1)
Christian M Beilstein, MD (1) · David M. Burger, PharmD PhD (1) · Javier Magrina, MD (1) · Nancy J Brown, MD (1)